Connect with us

Monkeypox

White House says administration is scaling up monkeypox efforts

“We’ve been working with community health partners, members of the LGBT community, and others to ensure that we are getting out good info”

Published

on

Dr. Ashish Jha participates in a press briefing, Tuesday, April 26, 2022 (Official White House File Photo by Cameron Smith)

WASHINGTON – Speaking with reporters Tuesday during in a press briefing, White House COVID-19 response coordinator Dr. Ashish Jha addressed the ongoing monkeypox outbreak and the administration’s response.

Referencing the declaration by Dr. Tedros the Director-General of the the World Health Organization labeling monkeypox a Public Health Emergency of International Concern, Dr. Jha told the press corps that the declaration by was a call to action to the world community to stop the spread of this virus. 
 
“The international community must work together to protect individuals that have been impacted by monkeypox and those most at risk of contracting the virus.  WHO’s declaration will allow the United States and other partners to better collaborate, to share data, and to get critical information out to high-risk communities,” Jha said. 

Pivoting to the Biden Administration’s response he noted, “Here at home, since the earliest days of this outbreak in the U.S. in mid-May, the Biden administration has deployed a robust, comprehensive strategy to combat monkeypox.  Our strategy has four key pillars, and I want to go through them.”

Jha then detailed the efforts by the federal government:

First is to dramatically scale up procurement, production, and distribution of vaccines.  Second is to significantly expand access to testing.  Third is to significantly expand access to treatments.  And fourth is outreach to communities most affected by the virus.

We have been working around the clock to ramp up our response and to make important progress in short order.  To date, we have distributed more than 300,000 vaccines to jurisdictions around the country.  We have procured more vaccines than any other country in the world, probably more than every other country in the world combined. 

FDA is working quickly to finalize the approval of nearly 800,000 additional doses, and we are getting ready to ship these doses to jurisdictions once FDA has finally approved them.

We have 1.3 million doses of TPOXX, the treatment for smallpox that can also be used for monkeypox, in our stockpile.  And we are working day and night to make access to that treatment easier for providers around the country.

When the first case of monkeypox was confirmed in the United States, we had the capacity to do 6,000 tests per week — much higher than demand — but we knew that testing at the time wasn’t as convenient for providers as it needed to be.  So the CDC immediately started working with five of the biggest commercial labs to get monkeypox testing going online so doctors can use their existing partnerships with commercial labs. 

Today, because of that work, there is capacity to do 80,000 tests per week, and we are continuing to do extensive outreach to providers to make testing easier. 

Jha then pointed out the fact that Biden Administration is keenly aware of the impact that monkeypox is having on the LGBTQ+ community.
 
Finally, we’ve been working on the ground with community health partners, members of the LGBT community, and others to ensure that we are getting out good information, that we are addressing concerns that they have, we are listening to their concerns,” he said. 
 
Jha told reporters that the federal government is taking the outbreak of the monkeypox virus seriously and is working on expanding access to testing, vaccines, and treatments, and “making sure that Americans understand what risks and challenges this virus faces and what the administration is doing to respond to it.”

When asked by a reporter, “Given the limited testing early on, how many more cases do you think there actually are right now in the United States than what we know about?”

Jha answered, “Yeah, so I would say — first of all, in terms of testing, you know, we had 6,000 tests available per week, which works out to about eight, nine hundred tests a day.  I don’t think testing capacity has been a major limitation.  One of the challenges has been that a lot of providers have found it difficult to actually order the tests.  That’s one of the reasons we brought in the national labs, because physicians are very comfortable using national labs. 

You know, obviously, we want to continue working on making sure testing is more and more widely available so that we’re tracking every case and identifying every case.  I don’t have a number of how many cases — further cases are out there, but I do expect, by the way, that as all these national labs now come online, as they have over the last week, I would not be surprised if we see an increase in cases as testing becomes more robust.  That’s a very normal part of any outbreak response — is that as testing ramps up, you tend to see an increase in cases because people can identify it more.”

Another reporter asked: “I guess the number is significantly higher than what we know right now?” In response Jha noted: “It’s very hard for me to make guesses on what the number is.  And I think the goal is to make testing easy, widespread, available so that people can order those tests.”

Jha was then asked: Just on the global response to monkeypox.  As we know, viruses don’t respect borders.  What is the U.S. able, willing, prepared to do to address that, especially since this affects communities that are often stigmatized, left out of public health interventions?” 

Jha replied: “Yeah, so we have had a very global — kind of a very strong engagement in the global community on monkeypox for years.  We have worked with multiple countries on the African continent where most of the disease has been endemic in the past.  We continue to have strong partnerships with multiple countries around building up laboratory capacity.  That same testing capacity we’re talking about here in the United States, it’s really essential that other countries have that as well.  We’re continuing that work. 

This outbreak obviously now is in many, many other countries as well.  And so we’re in constant conversations with our European colleagues, with colleagues in other parts of the world.  I think this public health emergency declaration will also further galvanize global response.  I’ll make a couple of more points.  I mean, the U.S. really, on monkeypox, has been a global leader.  We are the major funder of the company that makes the Jynneos vaccine.  We, in fact, have had a very large role to make sure that that vaccine exists and has come into being.

So U.S. global leadership on monkeypox, I think, is both longstanding, and we’re going to continue doing all of those things to make sure this really is a global response.”

In a follow-up Jha was asked:  “But any — any concrete deliverables that we might see?”

“Well, so we’re working with countries to do — so — and different countries have different needs,” Jha said and added, “Different countries have different technical needs.  So we are right now engaged in a lot of both bilateral and multilateral conversations with nations to figure out what help do they need, what kinds of technical and other kinds of expertise can we provide.”

After a series of back and forth over President Biden’s recent bout with the B.A.5 omicron variant of coronavirus the questions returned to monkeypox.

A reporter asked: “I wanted to go back to monkeypox and ask what the government’s response is to some of the backlash regarding the messaging and language that could perpetuate homophobia and transphobia, like we saw during the HIV epidemic?”

Jha answered: “Are there specific things you’re concerned about?  I mean, I think, very clear at this point that the community most affected is the LGBTQ community.  This is one of the reasons why I said we’ve been deeply engaged with them, both to share information, also to learn more and make sure that — that everybody is communicating in a way that’s both scientifically accurate and respectful. 

You know, obviously, it’s really important that we do not use this moment to propagate homophobic or transphobic messaging.  And I think it’s really important that we stick to the science, stick to the evidence, and do it in a way that’s respectful of people.”

The question arose over the federal government’s process for declaring monkeypox a health emergency:  “When will you decide, you know, whether it merits declaring a public — a public health emergency?  And what other factors would you need to look at?”

Jha:  “Yeah, it’s a good question.  This is a decision that’ll be made by Secretary Becerra, the Department of Health and Human Services.  You know, with any outbreak, that evaluation almost sort of begins day one.  People start looking at and thinking about, you know, when is that appropriate.  I think Secretary Becerra will make that decision when he thinks that doing so will help with the response. 

Obviously, a PHE opens up certain capabilities for the — for the Department of Health and Human Services.  I know those are conversations that are ongoing and continue, and that’ll be a decision made by Secretary Becerra.”

Dr. Jha was then asked: “And on the monkeypox vaccine, you know, is there consideration of invoking the DPA to produce more of it?  And how much do you estimate the U.S. would need total?”

Jha:  “Yeah, that’s a very good question.  Again, and I — what I will say is, right now we’ve — we have about 760, 780 thousand doses that we’re planning on making allocations about in the — in the next few days, pending FDA authorization, of course.

We’re looking at the company that makes it.  We’re looking at their ability to produce more.  We’re talking to them about contract manufacturing in the United States and being able to produce more vaccines here. 

So we’re looking at a whole range of options.  Obviously, if other tools that the federal government has at its disposal are helpful, we will be — we will not be shy about invoking those tools.  But right now, we are looking at these sets of factors to see how much more vaccine can we get in the United States.”

Continue Reading
Advertisement

Monkeypox

Federal authorities: 400K+JYNNEOS Monkeypox Vax doses now available

HHS noted that it has also worked to increase the availability of monkeypox tests nationwide by partnering with five commercial laboratories

Published

on

Screenshot/YouTube - U.S. Department of Health and Human Services

WASHINGTON – The U.S. Department of Health and Human Services (HHS), announced Monday that it is making up to 442,000 doses of the JYNNEOS vaccine available for states and local jurisdictions to order under an accelerated plan to combat the current monkeypox outbreak.  

“Ending the monkeypox outbreak is a critical priority for the Biden-Harris Administration,” said HHS Secretary Xavier Becerra in a statement released by the White House.

 “Every step of the way, we have accelerated our response including by significantly increasing vaccine supply and distribution, expanding access to tests, making treatments available for free, and educating the public on steps to reduce the risk of infection. FDA’s Emergency Use Authorization of intradermal injection of the JYNNEOS vaccine is allowing us to get more doses to jurisdictions faster than anticipated and will help end this national monkeypox outbreak. We will continue working with our state partners to ensure equitable and fair distribution of these vaccine doses to protect those most at risk and limit the spread of the virus.”

In addition, HHS noted that it has worked to increase the availability of monkeypox tests nationwide by partnering with five commercial laboratories. Since the start of the current outbreak, testing capacity has increased to 80,000 per week – up from 6,000 per week.

The Centers for Disease Control and Prevention (CDC), has also taken action to significantly reduce the burden in accessing treatment for monkeypox by decreasing the documentation required to access the antiviral treatment TPOXX and also allowing providers to start treatment more quickly.

In New York City, the Gothamist reported LGBTQ+ activists gathered outside Senate Majority Leader Chuck Schumer’s Senate district office in Manhattan on Sunday to demand better access to monkeypox testing and vaccines from the federal government.

Organizers with ACT UP New York, PrEP4All and members of the queer community that have been impacted by the monkeypox outbreak called for or an emergency use authorization of the tecovirimat, or Tpoxx vaccine, an investment in new testing that detects the virus before skin lesions appear and more educational outreach to all communities.

Medical providers in New York have called on the Biden administration to remove barriers to the antiviral to monkeypox known as Tpoxx, which aims to stop the virus from progressing once a person has already been infected – versus other vaccines typically used as a preventative measure.

Supply chain issues have plagued local health departments in the larger metropolitan areas where the largest populations of gay and bisexual men are residing. According to the CDC the principally affected group of persons infected with the virus are men who have sex with men and transgender individuals who have sex with men.

In California, the Los Angeles County Department of Public Health has nearly exhausted its limited supplies of the JYNNEOS and is anticipating resupply, but has paused its County-wide pre-registration link on its website, putting off scheduling new vaccine appointments. There are also shortages in San Francisco.

The Bay Area Reporter noted that the San Francisco Board of Supervisors interrupted its August recess on Monday to ratify the declaration and heard from Health Officer Dr. Susan Philip about how it could help the city get more of the Jynneos vaccine. (The city recently received 10,000 doses, less than is needed but way more than previous shipments.)

Continue Reading

Monkeypox

Monkeypox vax outages & bureaucracy impedes healthcare providers

CDC on Friday reported that the number of confirmed cases of the monkeypox virus has doubled in the past two weeks escalating to 11,177

Published

on

Photo Credit: State of California

LOS ANGELES – Frustrations are mounting as the campaign to vaccinate people against infection of the monkeypox virus is derailed by a critical supply shortage of vaccine doses with added bureaucratic obstacles in getting financial reimbursement to the healthcare providers and clinics dispensing the vaccine.

The Los Angeles County Department of Public Health has nearly exhausted its limited supplies of the JYNNEOS and is anticipating resupply, but has paused its County-wide pre-registration link on its website, putting off scheduling new vaccine appointments.

In one notable example, Public Health’s Monkeypox Vaccination Pop-Up Clinic at the West Hollywood Library exhausted its supply of the vaccine on Friday and ceased operations. According to a press release from West Hollywood city officials, more doses of vaccine are anticipated to be delivered by the federal government in the coming days, on a date to be determined. Once supply is reestablished, then operations will resume for the Pop-Up Clinic.

Exacerbating the crisis, the Centers for Disease Control and Prevention on Friday reported that the number of confirmed cases of the monkeypox virus has doubled in the past two weeks escalating to 11,177.

In Los Angeles County, the County Health Department said that the county’s monkeypox profile is similar to the national case load increase as the disease spreads.

Complicating the issue, in an action taken earlier this week, Michelle Baass, the Director
of the California Department of Health Care Services, (DHCS) announced that Medi-Cal will only reimburse Federally Qualified Health Centers (FQHCs) for monkeypox vaccine administration when provided during a face-to-face visit with a provider.

Reacting to Baass’ decision, a group of 17 healthcare providers for the LGBTQ community in California sent a letter to Director Baass expressing deep concerns regarding the seemingly arbitrary move, which ran counter to the history of state efforts during the coronavirus pandemic.

In the letter [embedded below] the signatories representing the 17 organizations stated:

This decision will significantly hamper the ability of FQHCs to respond to the monkeypox outbreak with the speed and urgency it requires and flies in the face of Governor Newsom’s declared State of Emergency.

As health care providers who serve a significant percentage of low-income LGBTQ+ Californians, we believe this decision is a flagrant example of institutionalized homophobia and we urge the department to reverse course immediately. Monkeypox vaccine administration by FQHCs should be reimbursed in the same way as COVID-19 vaccines.”

The letter also stated:

Regrettably, DHCS’ announcement this week will only make it harder for many of our most
vulnerable LGBTQ+ Medi-Cal patients to be vaccinated. In the FQHC setting, monkeypox
vaccines are generally administered outside of a primary care visit by a non-billable provider.
This allows us to vaccinate a significantly greater number of patients on a daily basis
.

Forcing Medi-Cal patients to have a face-to-face visit with a primary care provider will dramatically slow our current vaccination effort and make it even harder to control the current outbreak. In the time it takes for one individual to have their vitals taken and engage in a face-to-face visit with a primary care provider, FQHCs have the ability to vaccinate 15-20 people. DHCS’ policy makes absolutely no sense from a public health perspective and it screams of discrimination.

Anthony Cava, a spokesman for the California Department of Health Care Services, responded to the Blade’s inquiry over the facts of the letter laid out by the Healthcare provider signatories. However Cava ignored the implications of homophobia and discrimination specified in the letter:

“In response to the monkeypox public health emergency, the Department of Health Care Services (DHCS) appreciates the tremendous effort, focus, and compassion that our clinic partners are bringing to the important work of combatting this virus in their communities. Their hard work and dedication make them critical partners in our response.

DHCS is committed to working with the Centers for Medicare & Medicaid Services (CMS) to respond to monkeypox. DHCS will broadly seek federal approval to reimburse vaccine administration and applicable laboratory testing at 100 percent of the Medicare rate, once established. As part of this request, DHCS will seek federal approval to reimburse Federally Qualified Health Centers (FQHC), and similarly situated clinics that are paid an all-inclusive rate, the vaccine administration fee for vaccine-only visits, consistent with how we are reimbursing for COVID-19 vaccine-only visits. The requested federal approvals will also include reimbursement for vaccine administration performed by non-clinic providers.

At this time, DHCS has not yet received federal guidance regarding reimbursement policies for the administration of the monkeypox vaccine. However, DHCS has communicated with CMS about the urgent need for clarity. Pending the release of such guidance, we informed FQHC providers that we will reimburse them for care provided, which may include the administration of the vaccine if it is done as part of a clinic visit that includes addressing this virus.”

Aaron Fox, the Director of Government Relations for the Los Angeles LGBT Center responded to the DHCS statement:

“Our community cannot wait for DHCS and CMS to continue talking. We must have action on this yesterday and we are in a Public Health crisis and government bureaucracy and inaction is unacceptable and will only result in increased suffering in our community,” Fox told the Blade in a phone call late Friday.

Fox added that his perception of the government response is that while the Biden-Administration and California have declared a Public Health Emergency, in terms of immediate action taken thus far it is little more than saying, “oh look there’s a house on fire,” but neglecting to dial 911 and get the fire dept rolling.

The Blade also had a conversation by phone late Friday with Jim Mangia, President and CEO of St. John’s Community Health, a network of community clinics in the greater Los Angeles region:

“While I applaud the spirit of the DHCS response, however, spirit alone will not stop this outbreak. DHCS has the power to make decisions about reimbursement rates and services allowable under Medi-Cal so they can set an interim rate for monkey-pox administration at the same rate it was set under COVID-19. I’ll note though that it took DHCS over a year to reimburse clinics for the COVID-19 community clinic programs. We urge them to do the right thing now before its too late.”

At a federal level, this last week on Tuesday, as part of a decision by Secretary of Health & Human Services Xavier Becerra to issue a determination under Section 564 of the Federal Food, Drug and Cosmetic Act to justify emergency use authorization of vaccines, the FDA also ordered a new vaccine approach.

This would change injections of the JYNNEOS vaccine from the subcutaneous route (delivery of the vaccine under the fat layer underneath the skin) to the intradermal route (delivery of the vaccine into the layer of skin just underneath the top layer).

This would allow for healthcare providers to squeeze five doses out of what used to be just one dose, which the FDA said should increase the number of vaccine doses in the national stockpile from 441,000 to more than 2.2 million.

In a letter first obtained by the Washington Post and later by the Blade, [embedded below] Paul Chaplin the President & CEO of Bavarian Nordic A/S, the sole manufacturer of the JYNNEOS Monkeypox vaccine expressed grave misgivings over HHS Secretary Becerra’s plan to dilute the dosage.

“Bavarian Nordic (BN) is dedicated to assisting Governments around the globe to control the current monkeypox outbreak and is fully supportive of dose-sparing approaches, such as delaying the second vaccination. However, we do have some reservations on the ID approach, due to the very limited safety data available,” Chaplin wrote.

Addressing both the reimbursement issues raised by the community clinic networks as well as the supply chain issues, California State Senator Scott Wiener told the Blade in an email,

“The Administration has been a strong partner in our effort to fight monkeypox, and we’re working closely and collaboratively to ensure our response is as effective as possible. I’m confident we’ll be able to resolve this issue.”

Wiener (D-San Francisco) was appointed by California Senate President Pro Tem Toni Atkins (D-San Diego) to chair the newly-formed State Senate Select Committee on Monkeypox. Also appointed as members of the committee are Senators Susan Eggman (D-Stockton), John Laird (D-Santa Cruz), Rosilicie Ochoa Bogh (R-Yucaipa), Lena Gonzalez (D-Long Beach), and Richard Pan (D-Sacramento).

LADPH reported Friday that the total Monkeypox / Orthopox Confirmed Cases were 797 which
included Long Beach and Pasadena
which have separate independent health departments.

Los Angeles County (excl. Long Beach and Pasadena)753
Long Beach36
Pasadena8

Long Beach data as of August 11, 2022 at 12:00 AM.
Pasadena data as of August 10, 2022 at 5:30 PM.

CDC Monkeypox data table for August 12, 2022, 11,177 total cases:

LocationCases
Alabama30
Alaska2
Arizona170
Arkansas15
California1,945
Colorado111
Connecticut59
Delaware8
District Of Columbia328
Florida1,085
Georgia851
Hawaii12
Idaho9
Illinois771
Indiana78
Iowa15
Kansas3
Kentucky11
Louisiana103
Maine3
Maryland275
Massachusetts202
Michigan92
Minnesota66
Mississippi11
Missouri20
Montana2
Nebraska15
Nevada74
New Hampshire15
New Jersey293
New Mexico16
New York2,295
North Carolina138
North Dakota2
Ohio89
Oklahoma12
Oregon95
Pennsylvania298
Puerto Rico48
Rhode Island31
South Carolina60
South Dakota2
Tennessee67
Texas815
Utah69
Vermont2
Virginia175
Washington251
West Virginia4
Wisconsin31
Wyoming0

Continue Reading

Monkeypox

Right-wing media exploit monkeypox- retread anti-vax misinformation

These anti-vax talking points are intended to stigmatize LGBTQ people by framing promiscuity as the primary driver of the disease

Published

on

Graphic by Andrea Austria for Media Matters

By Mia Gingerich | WASHINGTON – As monkeypox presents an ever-increasing threat to Americans, predominantly gay and bisexual men, conservative media figures are exploiting the global health emergency to stoke fears of the COVID-19 vaccine and related health measures and to attack queer men. 

These anti-vax talking points are often invoked alongside AIDS-era rhetoric intended to stigmatize LGBTQ people by framing promiscuity as the primary driver of the disease and gay and bisexual men as culprits in — rather than victims of — the growing outbreak. This stigmatization has already reportedly resulted in violence against gay men.

During the last week of July, the U.S. reported both the fastest rise in and highest number of monkeypox cases worldwide, leading the Biden administration to declare a public health emergency on August 4. The virus, which is endemic in certain African countries, is usually rare in Europe and the U.S. However, the virus recently found its way to men who have sex with men (MSM), where it has proliferated primarily through sexual contact. The gay community has emphasized the need to warn about the risk the virus poses to MSM while not feeding into anti-gay rhetoric that depicts gay sexuality as immoral. 

Despite this plea from those most affected by the ongoing health crisis, right-wing media quickly responded to the spread of monkeypox with homophobia – recalling the vilification that gay men experienced during the AIDS epidemic. In addition to being impacted by the latest right-wing media smear campaign risking targeted violence against LGBTQ people, queer men are also less likely to seek medical care for monkeypox in countries where their sexuality is stigmatized.

Conservative media figures invoke COVID-19 conspiracy theories and criticism of health measures in coverage of monkeypox

From early on in their coverage of the monkeypox outbreak, right-wing media figures used the story to renew efforts to sow vaccine hesitancy and undermine COVID-19 health measures. Some far-right figures have even spread conspiracy theories that falsely assert the COVID-19 vaccine is directly responsible for the monkeypox outbreak. 

On May 24, The Daily Wire’s Candace Owens said on her show that “the first person who lines up to get a monkeypox vaccine, I’m going to laugh in your face.” Owens then suggested the World Health Organization, Bill Gates, and Dr. Anthony Fauci were involved in the spread of both diseases as part of “attempts at authoritarianism” and “globalism.” This claim coincides with the recent conservative conspiracy theory claiming the U.S. was ceding power to the WHO.

From the May 24, 2022, edition of Daily Wire’s Candace

Fox News’ Sean Hannity brought anti-vax conspiracy theorist Dr. George Fareed onto the August 8 edition of his radio show, where Fareed falsely claimed “the mass vaccination with these gene therapies, COVID vaccines, have the ability to weaken the immune system and make people more vulnerable to viral infection,” suggesting the vaccine could precipitate the spread of monkeypox. 

Far-right blog American Greatness posted an article on August 3 promoting the work of Shmuel Shapira, an Israeli scientist pushing similar claims as Fareed. The article claimed “Twitter censored Shapira” after the platform flagged a tweet of his as misinformation. Shapira’s tweet read, “It is well established the mRNA vaccines affect the natural immune system. A monkey pox outbreak following massive covid vaccination: Is not a coincidence.”

Right-wing media figures have also taken advantage of the recent health crisis to reignite their crusade against public health measures implemented during the COVID-19 pandemic. Conservative commentators claim that a double standard exists between government reactions to monkeypox and COVID-19, ignoring differences in how the two diseases spread. 

Podcaster Steven Crowder, amid a longer homophobic rant suggesting gay men were engaging in bestiality, claimed on August 2 that COVID-19 health measures were “politically motivated” and that masking and social distancing “didn’t make any difference whatsoever.” Crowder then contrasted those measures with the fact that Pride events still took place this year despite the spread of monkeypox, saying, “They won’t even cancel their gay San Francisco fuckfest.”

From the August 2, 2022, edition of Louder with Crowder, streamed on YouTube

An article for The Federalist titled “Americans Lost Fundamental Freedoms During Covid — But Halting Gay Orgies To Stop Monkeypox Is Too Far?” bemoaned COVID lockdowns and claimed, “We shut down the world for a virus that had no traceable transmission, it was entirely random. It really isn’t too much to ask for gay men to stop engaging in orgies and public sex events for their ‘mental health,’ their ‘self-esteem,’ and to continue ‘having fun.’”

On Twitter, right-wing personalities expressed a similar sentiment. 

Alt-right troll Mike Cernovich tweeted his criticism of public health advocate Dr. Gregg Gonsalves:

Far-right YouTuber Ian Miles Cheong continued his online anti-gay tirade on monkeypox:

Right-wing radio host Dan O’Donnell similarly tweeted:

Gay men are targeted with violence while right-wing media continues to depict them as threats

After the first cases of monkeypox were found among children in the U.S., LGBTQ advocates reported right-wing figures were using the news to falsely claim that gay men were guilty of abuse. This was a part of a larger attempt by right-wing media to use the monkeypox outbreak to depict LGBTQ people as a threat to society. By attempting to evoke the sort of stigmatizing rhetoric pushed during the AIDS epidemic that frames the MSM community as vectors of disease, right-wing media is feeding a culture of prejudice that has already resulted in violence against gay men. 

The above-mentioned article from The Federalist fearmongered that “as gay men spread the virus within their population at startling rates, the chances of it escaping into the mundane world through close contact in stores, crowded streets, or buses increases,” claiming that gay and bisexual men were spreading the disease through “truly selfish behavior [that] is endangering the rest of us.”

Right-wing talk show host Erick Erickson tweeted, “‘My orgy doesn’t affect you,’ said the man who spread monkeypox to the lady who worked at the gas station. Two weeks of no orgies to stop the spread is just too much to ask.”

On Hannity’s August 8 radio show, guest Dr. Brian Tyson said the virus would “spread to the heterosexual community if we don’t get a handle on the gay community to stop the transmission,” and claimed “the CDC and the NIH, they’re afraid to come out and tell the gay community to stop having intercourse until this pandemic goes away.”

On the August 5 edition of his show, Turning Point USA’s Charlie Kirk characterized the government response to monkeypox as an attempt to avoid offending “the alphabet mafia” of the LGBTQ community, saying, “You can’t go after the gay community for maybe doing something they shouldn’t be doing,” before declaring he would “not live through another lockdown or an erosion of our civil liberties by a corrupt or usurpatious government because we’re afraid to offend people. Don’t care, and you shouldn’t either.”

From the August 5, 2022, edition of The Charlie Kirk Show, streamed on YouTube   

The effects of right-wing media’s misinformation about the COVID-19 vaccine put their audience at serious risk. However, these conservative figures are now jeopardizing the health of millions of LGBTQ Americans as well by seeking to stigmatize their sexuality during a public health crisis.

**********************

Mia Gingerich is a researcher at Media Matters. She has a bachelor’s degree in politics and government from Northern Arizona University and has previously worked in rural organizing and local media.

********************

The preceding article was previously published by Media Matters for America and is republished by permission.

Continue Reading
Advertisement
Advertisement

Follow Us @LosAngelesBlade

Sign Up for Blade eBlasts

Popular